These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 21677423)
1. Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties. Walter T; Hommell-Fontaine J; Gouysse G; Pourreyron C; Nejjari M; Villaume K; Causeret S; Hervieu V; Poncet G; Roche C; Scoazec JY Neuroendocrinology; 2011; 94(3):200-8. PubMed ID: 21677423 [TBL] [Abstract][Full Text] [Related]
2. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture. Lawnicka H; Stepień H; Wyczółkowska J; Kolago B; Kunert-Radek J; Komorowski J Biochem Biophys Res Commun; 2000 Feb; 268(2):567-71. PubMed ID: 10679244 [TBL] [Abstract][Full Text] [Related]
4. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice. Weckbecker G; Raulf F; Bodmer D; Bruns C Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482 [TBL] [Abstract][Full Text] [Related]
5. [Inhibition of human gastric cancer metastasis by ocreotide in vitro and in vivo]. Wang C; Tang C Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):19-22. PubMed ID: 11953120 [TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Weckbecker G; Liu R; Tolcsvai L; Bruns C Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289 [TBL] [Abstract][Full Text] [Related]
7. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization. Yasui M; Yamamoto H; Ngan CY; Damdinsuren B; Sugita Y; Fukunaga H; Gu J; Maeda M; Takemasa I; Ikeda M; Fujio Y; Sekimoto M; Matsuura N; Weinstein IB; Monden M Clin Cancer Res; 2006 Aug; 12(15):4720-9. PubMed ID: 16899623 [TBL] [Abstract][Full Text] [Related]
8. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide]. Wang CH; Tang CW Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma. Sun CC; Zhang YS; Xue X; Cheng YN; Liu HP; Zhao CR; Lou HX; Qu XJ Eur J Pharmacol; 2011 Sep; 667(1-3):136-43. PubMed ID: 21704029 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours. Azoitei N; Pusapati GV; Kleger A; Möller P; Küfer R; Genze F; Wagner M; van Lint J; Carmeliet P; Adler G; Seufferlein T Gut; 2010 Oct; 59(10):1316-30. PubMed ID: 20732914 [TBL] [Abstract][Full Text] [Related]
11. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo]. Wang C; Tang C; Tang L Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709 [TBL] [Abstract][Full Text] [Related]
13. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419 [TBL] [Abstract][Full Text] [Related]
14. The role of angiogenesis in endocrine liver metastases: an experimental study. Pourreyron C; Poncet G; Roche C; Gouysse G; Nejjari M; Walter T; Villaume K; Jacquier MF; Bernard C; Dumortier J; Chayvialle JA; Bachelot T; Scoazec JY J Surg Res; 2008 Jan; 144(1):64-73. PubMed ID: 17643449 [TBL] [Abstract][Full Text] [Related]
15. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466 [TBL] [Abstract][Full Text] [Related]
16. [Effects of combination of octreotide and aspirin on proliferation of human hepatocellular carcinoma]. Tang CW; Tang LP; Wang CH Ai Zheng; 2002 Apr; 21(4):383-7. PubMed ID: 12452016 [TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784 [TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272 [TBL] [Abstract][Full Text] [Related]
19. [Effects of endocrine peptides on proliferation, migration and differentiation of human endothelial cells]. Marion-Audibert AM; Nejjari M; Pourreyron C; Anderson W; Gouysse G; Jacquier MF; Dumortier J; Scoazec JY Gastroenterol Clin Biol; 2000; 24(6-7):644-8. PubMed ID: 10962388 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Danesi R; Agen C; Benelli U; Paolo AD; Nardini D; Bocci G; Basolo F; Campagni A; Tacca MD Clin Cancer Res; 1997 Feb; 3(2):265-72. PubMed ID: 9815682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]